持田製薬(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証PRM | 医薬品 | 4534/E00947 | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2024/03/08 | 日証協 | 137,029株 | -21.11% | 287,752株 | -4.74% | 179,098株 | -16.68% | 35,400株 | -66.2% |
2024/03/01 | 日証協 | 173,696株 | -1.71% | 302,065株 | +293.47% | 214,941株 | +36.35% | 104,732株 | +383.55% |
2024/02/22 | 日証協 | 176,720株 | +26.63% | 76,770株 | -53.01% | 157,641株 | +31.54% | 21,659株 | -38.66% |
2024/02/16 | 日証協 | 139,552株 | +3.19% | 163,365株 | +2.57% | 119,841株 | -0.25% | 35,308株 | +4.85% |
2024/02/09 | 日証協 | 135,243株 | -0.52% | 159,264株 | -11.25% | 120,141株 | -7.4% | 33,675株 | -50.23% |
2024/02/02 | 日証協 | 135,955株 | -13.89% | 179,444株 | -11.64% | 129,739株 | -10.92% | 67,665株 | +631.99% |
2024/01/26 | 日証協 | 157,892株 | -2.24% | 203,072株 | +6.19% | 145,639株 | +9.01% | 9,244株 | -64.17% |
2024/01/19 | 日証協 | 161,509株 | -4.57% | 191,231株 | -0.23% | 133,599株 | -7.36% | 25,800株 | +1.98% |
2024/01/12 | 日証協 | 169,250株 | -22.88% | 191,664株 | +49.44% | 144,218株 | -26.87% | 25,300株 | +488.37% |
2024/01/05 | 日証協 | 219,458株 | +3.66% | 128,258株 | +46.7% | 197,218株 | +5.57% | 4,300株 | -94.36% |
2023/12/29 | 日証協 | 211,705株 | +25.02% | 87,426株 | -70.64% | 186,817株 | +2.13% | 76,302株 | +292.92% |
2023/12/22 | 日証協 | 169,341株 | -2.14% | 297,790株 | +95.09% | 182,925株 | +2.98% | 19,419株 | +165.98% |
2023/12/15 | 日証協 | 173,039株 | -3.49% | 152,646株 | +11.24% | 177,630株 | -0.84% | 7,301株 | -60.29% |
2023/12/08 | 日証協 | 179,288株 | -3.28% | 137,224株 | -0.51% | 179,128株 | -3.87% | 18,386株 | -40.09% |
2023/12/01 | 日証協 | 185,372株 | +8.81% | 137,924株 | -66.25% | 186,343株 | +6.88% | 30,687株 | -5.41% |
2023/11/24 | 日証協 | 170,363株 | -3.61% | 408,614株 | +29.23% | 174,340株 | +0.39% | 32,443株 | +14.9% |
2023/11/17 | 日証協 | 176,748株 | +3.96% | 316,192株 | +38.31% | 173,657株 | -1.02% | 28,236株 | +21.18% |
2023/11/10 | 日証協 | 170,008株 | +2.47% | 228,619株 | -16.09% | 175,439株 | +3.04% | 23,300株 | +30.74% |
2023/11/02 | 日証協 | 165,908株 | +4.67% | 272,449株 | +8.43% | 170,261株 | +5.66% | 17,822株 | -45.09% |
※株式分割は考慮していませんのでご注意ください。
Page Top